Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAGI3 | Q5TCQ9 | 1/20 | 0.45 |
| ▸ | TLR2 | O60603 | 4/20 | 0.43 |
| ▸ | GLP1R | P43220 | 9/20 | 0.43 |
| ▸ | CTSL | P07711 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24433583 | 0.97 | TLR2 (0.46) | MAGI3TLR2GLP1R | |
| SCHEMBL24433651 | 0.95 | MAGI3 (0.47) | MAGI3TLR2GLP1RCTSL | |
| SCHEMBL22483033 | 0.92 | MAGI3 (0.48) | MAGI3TLR2GLP1R | |
| SCHEMBL24433584 | 0.92 | MAGI3 (0.48) | MAGI3TLR2GLP1R | |
| SCHEMBL18973881 | 0.92 | MAGI3 (0.48) | MAGI3TLR2GLP1R | |
| SCHEMBL18973882 | 0.89 | GLP1R (0.51) | MAGI3TLR2GLP1R | |
| SCHEMBL22482833 | 0.86 | GLP1R (0.43) | MAGI3TLR2GLP1RCTSL | |
| SCHEMBL4418685 | 0.81 | CTSL (0.48) | MAGI3CTSL | |
| SCHEMBL30930090 | 0.80 | CTSL (0.47) | GLP1RCTSL | |
| SCHEMBL30165278 | 0.79 | GLP1R (0.48) | GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220153782-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING A NEUROLOGICAL CONDITION | MEMORYPLUS LTD. (IL) | 2022-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220153782-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING A NEUROLOGICAL CONDITION | NLN, SMN1; SMN2, AQP4 | MAGI3 4025/4885TLR2 3465/4885GLP1R 311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.